Xiangping Liu
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
Papers in
-
- Circular RNAs in diseases 8
- RNA modifications and cancer 6
- RNA Interference and Gene Delivery 6
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 7
- Co-authors
- Haibo Wang (10 shared papers)Ruyong Yao (11 shared papers)Funian Li (6 shared papers)Shoujun Zhu (5 shared papers)Zhi‐Dong Lv (4 shared papers)Bin Kong (3 shared papers)Yingxiang Du (3 shared papers)Weijun Zhao (1 shared paper)
- Journals
- Oncology Reports (4 papers)PLoS ONE (4 papers)Journal of Experimental & Clinical Cancer Research (3 papers)Chemical Science (2 papers)Journal of Photochemistry and Photobiology A Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesSaint Kitts and Nevis
In The Last Decade
Xiangping Liu
88 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 137
- Cancer Research 253
- Molecular Medicine 75
- Molecular Biology 662
- Oncology 220
- Immunology 130
Countries citing papers authored by Xiangping Liu
This map shows the geographic impact of Xiangping Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangping Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangping Liu more than expected).
Fields of papers citing papers by Xiangping Liu
This network shows the impact of papers produced by Xiangping Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangping Liu. The network helps show where Xiangping Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiangping Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo. | 2014 | 117 |
| 2 | 2010 | 87 | |
| 3 | 2014 | 73 | |
| 4 | 2022 | 60 | |
| 5 | 2019 | 55 | |
| 6 | 2016 | 53 | |
| 7 | 2017 | 46 | |
| 8 | 2021 | 44 | |
| 9 | 2017 | 39 | |
| 10 | 2013 | 38 | |
| 11 | 2017 | 33 | |
| 12 | 2020 | 32 | |
| 13 | 2017 | 27 | |
| 14 | 2009 | 23 | |
| 15 | 2009 | 23 | |
| 16 | 2020 | 22 | |
| 17 | 2023 | 20 | |
| 18 | 2015 | 20 | |
| 19 | 2010 | 20 | |
| 20 | 2018 | 18 |
About Xiangping Liu
Xiangping Liu is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Genetics, having authored 95 papers that have together received 1.3k indexed citations. Recurring topics across this work include Circular RNAs in diseases (8 papers), MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers), Nanoplatforms for cancer theranostics (6 papers), RNA Interference and Gene Delivery (6 papers), Virus-based gene therapy research (5 papers) and Luminescence and Fluorescent Materials (5 papers). The work is most often cited by research in Cancer Research (253 citations), Molecular Medicine (75 citations), Molecular Biology (662 citations), Oncology (220 citations) and Immunology (130 citations). Xiangping Liu has collaborated with scholars based in China, United States and Saint Kitts and Nevis. Frequent co-authors include Haibo Wang, Ruyong Yao, Funian Li, Shoujun Zhu, Zhi‐Dong Lv, Bin Kong, Yingxiang Du, Weijun Zhao, Qian Dong and Yijing Du. Their work appears in journals such as Oncology Reports, PLoS ONE, Journal of Experimental & Clinical Cancer Research, Chemical Science and Journal of Photochemistry and Photobiology A Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.